These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1587536)

  • 1. Absence of p53 germ-line mutations in bilateral breast cancer patients.
    Lidereau R; Soussi T
    Hum Genet; 1992 May; 89(2):250-2. PubMed ID: 1587536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inherited p53 gene mutations in breast cancer.
    Sidransky D; Tokino T; Helzlsouer K; Zehnbauer B; Rausch G; Shelton B; Prestigiacomo L; Vogelstein B; Davidson N
    Cancer Res; 1992 May; 52(10):2984-6. PubMed ID: 1581912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of germline mutations of exons 5 to 8 of the P53 gene in 26 breast cancer families from the north of France.
    Preudhomme C; Fenaux P; Peyrat JP; Fournier J; Bonneterre J; Vennin P
    Eur J Cancer; 1993; 29A(10):1476-8. PubMed ID: 8398277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated frequency and functional activity of a specific germ-line p53 intron mutation in familial breast cancer.
    Lehman TA; Haffty BG; Carbone CJ; Bishop LR; Gumbs AA; Krishnan S; Shields PG; Modali R; Turner BC
    Cancer Res; 2000 Feb; 60(4):1062-9. PubMed ID: 10706125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms.
    Malkin D; Jolly KW; Barbier N; Look AT; Friend SH; Gebhardt MC; Andersen TI; Børresen AL; Li FP; Garber J
    N Engl J Med; 1992 May; 326(20):1309-15. PubMed ID: 1565144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No evidence for germline mutations in exons 5-9 of the p53 gene in 25 breast cancer families.
    Warren W; Eeles RA; Ponder BA; Easton DF; Averill D; Ponder MA; Anderson K; Evans AM; DeMars R; Love R
    Oncogene; 1992 May; 7(5):1043-6. PubMed ID: 1570151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of germ-line mutations in the p53 gene exons 4 to 8 in patients with late-onset second malignant neoplasms.
    Lalle P; Moyret C; Bignon YJ
    Cancer Genet Cytogenet; 1994 Sep; 76(2):148-50. PubMed ID: 7923066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A germ line mutation in exon 5 of the p53 gene in an extended cancer family.
    Law JC; Strong LC; Chidambaram A; Ferrell RE
    Cancer Res; 1991 Dec; 51(23 Pt 1):6385-7. PubMed ID: 1933902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 germline mutations in Li-Fraumeni syndrome.
    Santibáñez-Koref MF; Birch JM; Hartley AL; Jones PH; Craft AW; Eden T; Crowther D; Kelsey AM; Harris M
    Lancet; 1991 Dec; 338(8781):1490-1. PubMed ID: 1683921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germ-line p53 mutations in 15 families with Li-Fraumeni syndrome.
    Frebourg T; Barbier N; Yan YX; Garber JE; Dreyfus M; Fraumeni J; Li FP; Friend SH
    Am J Hum Genet; 1995 Mar; 56(3):608-15. PubMed ID: 7887414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of germline mutations in exons 5-9 of the p53 gene in patients with Li-Fraumeni-like (SBLA) and familial adenomatous polyposis heritable cancer syndromes.
    Moore SK; Zambrano N; Lynch HT; Lipkin M; Kopelovich L
    Cancer Genet Cytogenet; 1996 Sep; 90(2):125-9. PubMed ID: 8830720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 Germline mutation in a patient with Li-Fraumeni Syndrome and three metachronous malignancies.
    Pötzsch C; Voigtländer T; Lübbert M
    J Cancer Res Clin Oncol; 2002 Aug; 128(8):456-60. PubMed ID: 12200603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germ-line splicing mutation of the p53 gene in a cancer-prone family.
    Warneford SG; Witton LJ; Townsend ML; Rowe PB; Reddel RR; Dalla-Pozza L; Symonds G
    Cell Growth Differ; 1992 Nov; 3(11):839-46. PubMed ID: 1467311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germ-line mutations of the p53 tumor suppressor gene in patients with high risk for cancer inactivate the p53 protein.
    Frebourg T; Kassel J; Lam KT; Gryka MA; Barbier N; Andersen TI; Børresen AL; Friend SH
    Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6413-7. PubMed ID: 1631137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High frequency of germline p53 mutations in childhood adrenocortical cancer.
    Wagner J; Portwine C; Rabin K; Leclerc JM; Narod SA; Malkin D
    J Natl Cancer Inst; 1994 Nov; 86(22):1707-10. PubMed ID: 7966399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Li-Fraumeni syndrome].
    Frebourg T
    Bull Cancer; 1997 Jul; 84(7):735-40. PubMed ID: 9339200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families.
    Birch JM; Hartley AL; Tricker KJ; Prosser J; Condie A; Kelsey AM; Harris M; Jones PH; Binchy A; Crowther D
    Cancer Res; 1994 Mar; 54(5):1298-304. PubMed ID: 8118819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of p53 tumor suppressor gene in families with multiple glioma patients.
    Paunu N; Syrjäkoski K; Sankila R; Simola KO; Helén P; Niemelä M; Matikainen M; Isola J; Haapasalo H
    J Neurooncol; 2001 Dec; 55(3):159-65. PubMed ID: 11859970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 mutations in breast cancer.
    Coles C; Condie A; Chetty U; Steel CM; Evans HJ; Prosser J
    Cancer Res; 1992 Oct; 52(19):5291-8. PubMed ID: 1394133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exclusion of a p53 germline mutation in a classic Li-Fraumeni syndrome family.
    Evans SC; Mims B; McMasters KM; Foster CJ; deAndrade M; Amos CI; Strong LC; Lozano G
    Hum Genet; 1998 Jun; 102(6):681-6. PubMed ID: 9703430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.